New wound wash could speed ulcer healing
NCT ID NCT07607106
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new liquid treatment for chronic wounds like leg and foot ulcers. The goal is to clean the wound by removing dead tissue and bacteria, which may help it heal. About 80 people aged 60 and older will be randomly assigned to get either the new treatment or a standard gel. The study lasts 4 weeks and involves 11 visits to measure wound size, bacteria, and pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria A pure or mixed venous ulcer, or a diabetic, neuropathic, or neuroischemic foot ulcer, greater than or equal to 4 cm² and less than or equal to 30 cm² with critical colonization. A duration of the ulcer greater than or equal to 2 months and less than or equal to 2 years. Age over 60 years: due to the higher prevalence of ulcers in adults over 60 years of age. An ankle-brachial index between 0.6 and 1.3. Exclusion criteria Morbid obesity (BMI \> 35) History of cancer treatment in the last year Uncontrolled diabetes (Glycated Hemoglobin above 10 mg/dL) Uncontrolled hypertension (blood pressure readings greater than 140/90 mmHg) Patients with a known allergy to the components of the products under study. Patients with signs of infection or undergoing antibiotic therapy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ulcer foot are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Universidad del Desarrollo
RECRUITINGSantiago, Metropolitana de Santiago, Chile
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 30 patients to test if nutrition tracking boosts wound healing
- Placental grafts show promise for stubborn diabetic foot sores
- Cord tissue patches aim to heal stubborn diabetic foot sores
- Placental grafts may speed healing of stubborn diabetic foot sores
- Could CO₂ baths heal stubborn diabetic foot sores?
- Gene therapy injection aims to heal diabetic foot sores